Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 ...

Enrollment is complete for the randomized part of ENHANCE, a Phase 3 trial testing a new dosing schedule for Briumvi in ...

Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...

Because of how unpredictable MS symptom flares can be, columnist Desiree Lama often finds herself living a sheltered life.

First UK patient with multiple sclerosis treated with CAR T cell therapy: United Kingdom Wednesday, October 29, 2025, 15:00 Hrs [IST] A patient with multiple sclerosis has become ...

A major UK-wide study led by researchers based in Liverpool has revealed the profound impact of multiple sclerosis (MS) on ...

BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...

Many people with MS are heat sensitive, so keeping cool can help. There are cooling vests and other types of clothing available, and cold drinks, hydration, shady locations, and a hat can help.

Peripheral neuropathy can be a symptom of chronic Lyme disease, causing burning, tingling, and numbness in extremities ...

TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...